Medicine Overview
Adult Dose
| Clinical Information | Administration Information |
|---|---|
|
Age: Adults |
Dose: Intravenous Emulsion – 1 g to 3 g triglycerides/kg body weight/day Note: 1g triglycerides corresponds to 10 ml Intralipid 10%. Within the upper limit of 3 g triglycerides/kg body weight/day, Intralipid can contribute up to 70% of energy requirements, including in patients with highly increased energy requirements. The infusion rate for Intralipid 10% should not exceed 500 ml in 5 hours. |
Child Dose
| Clinical Information | Administration Information |
|---|---|
|
Age: Neonates and infants |
Dose: Intralipid 10% – 0.5-4 g triglycerides/kg body weight/day Note: 1g triglycerides corresponds to 10 ml Intralipid 10%. The rate of infusion should not exceed 0.17 g triglycerides/kg body weight/hour (4 g in 24 hours). The rates given are maximum rates and no attempt should be made to exceed these in order to compensate for missed doses. |
|
Age: Prematures and low birthweight neonates |
Dose: Intralipid 10% – 0.5-1 g/kg body weight/day (Initial dosage) Frequency: continuously Duration: 24 hours Note: Followed by a successive increase by 0.5-1 g/kg body weight/day up to 2g/kg body weight/day. Only with close monitoring of serum triglyceride concentration, liver tests and oxygen saturation may the dosage be increased to 4 g/kg body weight/day. The rate of infusion should not exceed 0.17 g triglycerides/kg body weight/hour (4 g in 24 hours). The rates given are maximum rates and no attempt should be made to exceed these in order to compensate for missed doses. |
Administration
- Follow specific administration instructions from healthcare provider
- Usually part of nutritional supplementation
Side Effect
- Intralipid infusion may cause a rise in body temperature and
- less frequently
- shivering
- chills and nausea/vomiting (incidenceLess than 1%)
Drug Interaction
Drug Interaction
| Drug Name | Risk Factors |
|---|---|
|
No interactions listed
|
-
|
Disease Interaction
Disease Interaction
| Disease Name | Risk Factors |
|---|---|
|
Acute shock
|
Risk of cardiovascular complications
|
|
Severe hyperlipemia
|
Can worsen lipid disorders
|
Pregnancy
Pregnancy
Lactation
Special Use
Precaution
Overdose
Pharmacology
Storage
Details coming soon
Data Sources
Clinical & regulatory information on this page is compiled from the following government sources:
DISCLAIMER: This drug information content is provided for informational purposes only and is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Patients should always consult their physician with any questions regarding a medical condition and to obtain medical advice and treatment.